Four more medical marijuana companies – including multistate operator Curaleaf – have been approvedby Pennsylvania regulators to grow MMJ that state universities can use for research.
Curaleaf, which is based in Massachusetts but seeking a license to sell medical marijuana in Pennsylvania, is contracted to grow MMJ for the Perelman School of Medicine at the University of Pennsylvania, according to the Tribune-Review.
- Laurel Harvest Labs, partnering with Lewis Katz School of Medicine at Temple University.
- CannTech, partnering with Lake Erie College of Osteopathic Medicine.
- Organic Remedies, partnering with Philadelphia College of Osteopathic Medicine.
Those four alliances coupled withthree partnershipsapproved last Junebring Pennsylvania within one of its limit of eight entities that are permitted under state law to grow, process and supply marijuana to research institutions.
Only the University of Pittsburgh School of Medicine still is seeking to contract with a medical marijuana cultivator.
The results of such research partnerships couldencourage more physicians to recommend medical marijuana and eventually lead to increased sales.
Medical marijuana sales in Pennsylvania topped $132 million in 2018, the MMJ program’s first year.
Pure Cannabis Hemp Oil
- Pure CBD Tincture, derived from organic, US-harvested hemp, lab-tested for quality.
- Clinically proven therapeutic effects.
- Relieves anxiety and stress
- Eliminates chronic pain and aches
- Regulates mood and sleep patterns
- Enhances focus and clarity
additional info, George Scorsis Liberty Health Sciences
Originally posted on Pennsylvania approves four more cannabis firms for research via Cannabis Industry News
No comments:
Post a Comment